Bernstein SocGen Group Upgrades Beam Therapeutics Inc (BEAM) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts BEAM Hot Sheet
Price: $23.79 -1.08%
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Join SI Premium – FREE
Bernstein SocGen Group analyst William Pickering upgraded Beam Therapeutics Inc (NASDAQ: BEAM) from Market Perform to Outperform with a price target of $37.00 (from $35.00).
For an analyst ratings summary and ratings history on Beam Therapeutics Inc click here. For more ratings news on Beam Therapeutics Inc click here.
Shares of Beam Therapeutics Inc closed at $26.36 yesterday.
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- Morgan Stanley Upgrades Lockheed Martin (LMT) to Overweight
- Broadsoft (BSFT) PT Raised to $35 at Raymond James
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
